Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Hope for the Honey Bee?

04.08.2014

Peptide-polyketide antibiotic from the pathogen that causes American Foulbrood

Infections with American foulbrood can destroy entire bee populations. A team of German and Dutch researchers has now isolated metabolic products of the pathogen that causes it, Paenibacillus larvae. The structures of the products have been identified, providing insights into the unusual biosynthetic pathways by which they are made. These new findings could help to clarify the mechanisms of infection and thus to find points of attack for effectively combating bee disease. As the researchers report in the journal Angewandte Chemie, these paenilamicins have antibiotic effects that may also be of use in human medicine.


The honey bee is one of the most important pollinators in our agricultural and subnatural ecosystems. Our supply with fruit, nuts, and vegetables depends significantly on the fact that enough honey bees fly to the flowers of these plants. In recent years, pesticides and other environmental factors have posed massive health threads to bees. Infectious diseases can cause the death of bee populations. The American foulbrood of bees is a frequently encountered notifiable animal disease which causes infected larvae to essentially disintegrate.

Currently, not enough is known about the molecular mechanisms of the infection to effectively combat this disease. A team at the Technical University of Berlin, the Institute for Bee Research in Hohen Neuendorf, and the University of Leiden (Netherlands) has now gained some new insights: The genome of the pathogen contains genes for an interesting class of natural compounds, peptide-polyketide hybrids with antibacterial and antimycotic effects. The researchers found the special biosynthetic pathways for the formation of these metabolites, which does not use ribosomes, to be fascinating.

The team headed by Roderich Süssmuth and Elke Genersch was able to isolate several of these paenilamicins. They were then able to determine their structures and to characterize their amazing bioactivity: The bacteria release these compounds after they have infected bee larvae in order to keep competitors at bay. Paenibacillus larvae thus effectively kills off the bacterium Paenibacillus alvei in the intestines of the larvae, for example.

The scientists hope that their new insights into the paenilamicins and their biosynthetic pathways will lead to new approaches for combating foulbrood. In addition, the antibiotic effects of these substances could be a starting point for the development of novel human and veterinary pharmaceuticals.

About the Author

Dr Roderich Süssmuth is Professor for Chemical Biology at Technische Universität Berlin. His main specialty is the discovery and biosynthesis investigation of new secondary metabolites from microorganisms and their profiling as antiinfective drugs. He is a Fellow of the Cluster of Excellence “UniCat” coordinated by TU Berlin.

Author: Roderich Süssmuth, Technische Universität Berlin (Germany), http://www.biochemie.tu-berlin.de/

Title: Paenilamicin: Structure and Biosynthesis of a Hybrid Nonribosomal Peptide/Polyketide Antibiotic from the Bee Pathogen Paenibacillus larvae

Angewandte Chemie International Edition, Permalink to the article: http://dx.doi.org/10.1002/anie.201404572

Roderich Süssmuth | Angewandte Chemie

More articles from Life Sciences:

nachricht Rice University lab runs crowd-sourced competition to create 'big data' diagnostic tools
30.06.2016 | Rice University

nachricht A protein coat helps chromosomes keep their distance
30.06.2016 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Thousands on one chip: New Method to study Proteins

Since the completion of the human genome an important goal has been to elucidate the function of the now known proteins: a new molecular method enables the investigation of the function for thousands of proteins in parallel. Applying this new method, an international team of researchers with leading participation of the Technical University of Munich (TUM) was able to identify hundreds of previously unknown interactions among proteins.

The human genome and those of most common crops have been decoded for many years. Soon it will be possible to sequence your personal genome for less than 1000...

Im Focus: Optical lenses, hardly larger than a human hair

3D printing enables the smalles complex micro-objectives

3D printing revolutionized the manufacturing of complex shapes in the last few years. Using additive depositing of materials, where individual dots or lines...

Im Focus: Flexible OLED applications arrive

R2D2, a joint project to analyze and development high-TRL processes and technologies for manufacture of flexible organic light-emitting diodes (OLEDs) funded by the German Federal Ministry of Education and Research (BMBF) has been successfully completed.

In contrast to point light sources like LEDs made of inorganic semiconductor crystals, organic light-emitting diodes (OLEDs) are light-emitting surfaces. Their...

Im Focus: Unexpected flexibility found in odorant molecules

High resolution rotational spectroscopy reveals an unprecedented number of conformations of an odorant molecule – a new world record!

In a recent publication in the journal Physical Chemistry Chemical Physics, researchers from the Max Planck Institute for the Structure and Dynamics of Matter...

Im Focus: 3-D printing produces cartilage from strands of bioink

Strands of cow cartilage substitute for ink in a 3D bioprinting process that may one day create cartilage patches for worn out joints, according to a team of engineers. "Our goal is to create tissue that can be used to replace large amounts of worn out tissue or design patches," said Ibrahim T. Ozbolat, associate professor of engineering science and mechanics. "Those who have osteoarthritis in their joints suffer a lot. We need a new alternative treatment for this."

Cartilage is a good tissue to target for scale-up bioprinting because it is made up of only one cell type and has no blood vessels within the tissue. It is...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Quantum technologies to revolutionise 21st century - Nobel Laureates discuss at Lindau

30.06.2016 | Event News

International Conference ‘GEO BON’ Wants to Close Knowledge Gaps in Global Biodiversity

28.06.2016 | Event News

ERES 2016: The largest conference in the European real estate industry

09.06.2016 | Event News

 
Latest News

Modeling NAFLD with human pluripotent stem cell derived immature hepatocyte like cells

30.06.2016 | Health and Medicine

Rice University lab runs crowd-sourced competition to create 'big data' diagnostic tools

30.06.2016 | Life Sciences

A drop of water as a model for the interplay of adhesion and stiction

30.06.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>